Newark Beth Israel MC is a clinical research site located in Newark, New Jersey, United States 07112-2027.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Newark Beth Israel MC has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Sickle Cell Disease.
Sponsors: Novo Nordisk A/S.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Newark Beth Israel MC has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Newark Beth Israel MC has 1 clinical trials on record, with 1 currently active. Their work covers Sickle Cell Disease.
Newark Beth Israel MC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.